The European Union's medicines regulator said Tuesday it has started to evaluate BioNTech-Pfizer's COVID booster shot to vaccinate children aged between 12 and 15.
The European Medicines Agency (EMA) last week said it would soon rule on a similar application to give the booster to teens aged 16 and 17.
And now the EMA "has started evaluating an application for the use of a booster dose of Comirnaty in adolescents aged 12 to 15 years," the EU watchdog said.
"An application in older adolescents aged 16 to 17 years is also ongoing," the EMA added.